EcoDrugPlus

Serine/threonine-Protein Kinase Pak 4-Like

Ensembl ID : ENSCMIG00000001109
Gene Symbol: LOC103174233
3 Cross references
163 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSCMIG00000002488
Gene Symbol: LOC103179140
3 Cross references
250 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSCMIG00000001781
Gene Symbol: SERPINC1
3 Cross references
202 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSCMIG00000010532
Gene Symbol: SIGMAR1
3 Cross references
206 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSCMIG00000000676
Gene Symbol: SIRT1
3 Cross references
159 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSCMIG00000013561
Gene Symbol: SMO
4 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSCMIG00000013049
Gene Symbol: SCNN1B
4 Cross references
151 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Gamma

Ensembl ID : ENSCMIG00000013060
Gene Symbol: SCNN1G
3 Cross references
155 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSCMIG00000008660
Gene Symbol: SCN4A
3 Cross references
127 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSCMIG00000018145
Gene Symbol: SCN8A
3 Cross references
276 Possible Orthologues:

Sodium/glucose Cotransporter 2-Like

Ensembl ID : ENSCMIG00000001385
Gene Symbol: LOC103174284
2 Cross references
200 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSCMIG00000007050
Gene Symbol: LOC103177451
4 Cross references
328 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).